Johnson & Johnson is dropping a partnership with Genmab centered around a CD38 monoclonal antibody, prompting the latter company to discontinue development of the program. Back in 2019, the companies ...
Data consultancy Jordan & Jordan has developed an AI-enabled tool for data professionals to query suppliers’ data contracts and answer questions about data license agreements more quickly. Dubbed GARD ...
Nanobiotix (NASDAQ:NBTX) traded higher on Thursday after the French biotech announced initial results from a Phase 1 trial for JNJ-1900 (NBTXR3), a cancer injection developed by the company in ...
Jacobs (NYSE: J) has been selected by Hut 8 (NASDAQ: HUT), an energy infrastructure platform, to deliver Engineering, Procurement and Construction Management (EPCM) services for its River Bend data ...
The integration of Fusion with FactSet was prompted by J.P. Morgan's institutional clients, who wanted to receive J.P. Morgan data using modern technology, according to Jason Mirsky, J.P. Morgan ...
Johnson & Johnson (NYSE:JNJ) said updated data from a Phase 1b study of Talvey in combination with Darzalex Faspro and pomalidomide showed an overall response rate of 82% in patients with relapsed or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback